World Courier Weighs In On Logistics Of Cell & Gene Therapy Supply Chain
For the first time, cell and gene therapy, a treatment particularly promising for poorly and unmet diseases, can be said to have a bright future. While these therapies are gaining traction and attention, short delivery windows, changing regulations, and storage and temperature requirements are just a few challenges that plague the cell and gene therapy supply chain. World Courier is no stranger to these challenges. For more than 45 years, the company has provided specialty logistics for the transport and storage of time- and temperature-sensitive products, and now they’re taking on cell and gene therapy. Simon Ellison, cell and gene therapy service director at World Courier, discusses the importance of a personalized supply chain in cell and gene therapy and the logistics platform World Courier is developing to address some of its most pressing hurdles.
For the full article, visit Pharmaceutical Processing.